社会机器人辅助培训对帕金森病中的社会认知和认知功能的有效性:与主动对照组进行比较
G Figliano1, L Miraglia1, F Manzi2
1Research Center on Theory of Mind and Social Competence in the Lifespan (CeRiToM), Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy.
Asian journal of psychiatry
|February 15, 2026
概括
社会辅助机器人 (SAR) 培训改善了早期帕金森症患者的认知和社会功能.
科学领域:
- 老年学是指老年学的学科.
- 神经科学是一个神经科学.
- 人与计算机的交互
背景情况:
- 帕金森病 (PD) 和衰老与认知和社会认知能力的下降有关.
- 社会辅助机器人 (SARs) 显示出治疗干预的潜力.
- 早期干预可以减轻与年龄相关的认知变化.
研究的目的:
- 评估12周SAR培训计划对社会认知和认知功能的有效性.
- 为了比较SAR训练对早期PD患者和健康的老年人的影响.
- 评估基于SAR的干预措施的可行性和遵守性.
主要方法:
- 11名患有早期PD的个人和9名健康的老年人参与了这项研究.
- 使用Pepper机器人进行了为期12周的干预.
- 混合设计的重复措施 ANOVAs分析了干预前后的评估.
主要成果:
- 在两组中都观察到高坚持率 (90%).
- 在全球认知,执行功能和思维理论 (ToM) 任务 (p < .05) 中发现了显著的改善.
- 无论是PD患者还是健康的成年人,都在干预期间训练的技能都得到了改进.
结论:
- 基于SAR的干预措施在改善认知和社会功能方面是可行的和有效的.
- 该培训有利于患有早期PD的个人和健康的老年人.
- 在支持健康的认知和社会衰老方面,SAR培训可能具有预防性价值.
更多相关视频
14:56The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb
Published on: September 23, 2018
9.5K
04:49Author Spotlight: Enhancing Post-Stroke Upper Limb Rehabilitation with Robotic Technologies for Improved Motor Recovery and Functional Outcomes
Published on: September 6, 2024
1.6K
相关概念视频
01:24Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
01:15Parkinson's Disease: Overview
2.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K